178 related articles for article (PubMed ID: 18294103)
1. Alpha-fetoprotein and other tumour-associated antigens for immunotherapy of hepatocellular cancer.
Evdokimova VN; Butterfield LH
Expert Opin Biol Ther; 2008 Mar; 8(3):325-36. PubMed ID: 18294103
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.
Mizukoshi E; Nakamoto Y; Arai K; Yamashita T; Sakai A; Sakai Y; Kagaya T; Yamashita T; Honda M; Kaneko S
Hepatology; 2011 Apr; 53(4):1206-16. PubMed ID: 21480325
[TBL] [Abstract][Full Text] [Related]
3. Immunobiology and gene-based immunotherapy of hepatocellular carcinoma.
Geissler M; Mohr L; Ali MY; Grimm CF; Ritter M; Blum HE
Z Gastroenterol; 2003 Nov; 41(11):1101-10. PubMed ID: 14648380
[TBL] [Abstract][Full Text] [Related]
4. Cell-mediated immune responses to alpha-fetoprotein and other antigens in hepatocellular carcinoma.
Behboudi S; Boswell S; Williams R
Liver Int; 2010 Apr; 30(4):521-6. PubMed ID: 20040052
[TBL] [Abstract][Full Text] [Related]
5. Patient-derived dendritic cells transduced with an a-fetoprotein-encoding adenovirus and co-cultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against hepatocellular carcinoma cells.
González-Carmona MA; Märten A; Hoffmann P; Schneider C; Sievers E; Schmidt-Wolf IG; Sauerbruch T; Caselmann WH
Liver Int; 2006 Apr; 26(3):369-79. PubMed ID: 16584401
[TBL] [Abstract][Full Text] [Related]
6. Alpha fetoprotein is more than a hepatocellular cancer biomarker: from spontaneous immune response in cancer patients to the development of an AFP-based cancer vaccine.
Bei R; Mizejewski GJ
Curr Mol Med; 2011 Oct; 11(7):564-81. PubMed ID: 21707514
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapeutic strategies for hepatocellular carcinoma.
Butterfield LH
Gastroenterology; 2004 Nov; 127(5 Suppl 1):S232-41. PubMed ID: 15508089
[TBL] [Abstract][Full Text] [Related]
8. The immunosuppression role of alpha-fetoprotein in human hepatocellular carcinoma.
Meng W; Bai B; Bai Z; Li Y; Yue P; Li X; Qiao L
Discov Med; 2016 Jun; 21(118):489-94. PubMed ID: 27448785
[TBL] [Abstract][Full Text] [Related]
9. Alpha-Fetoprotein and Hepatocellular Carcinoma Immunity.
Wang X; Wang Q
Can J Gastroenterol Hepatol; 2018; 2018():9049252. PubMed ID: 29805966
[TBL] [Abstract][Full Text] [Related]
10. Low-dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4+ T-cell responses in patients with advanced HCC.
Greten TF; Ormandy LA; Fikuart A; Höchst B; Henschen S; Hörning M; Manns MP; Korangy F
J Immunother; 2010; 33(2):211-8. PubMed ID: 20139774
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of hepatocellular carcinoma.
Butterfield LH; Ribas A
Expert Opin Biol Ther; 2002 Feb; 2(2):123-33. PubMed ID: 11849113
[TBL] [Abstract][Full Text] [Related]
12. Potential of immunotherapy for hepatocellular carcinoma.
Breous E; Thimme R
J Hepatol; 2011 Apr; 54(4):830-4. PubMed ID: 21145836
[TBL] [Abstract][Full Text] [Related]
13. Identification of an HLA-A*24:02-restricted α-fetoprotein signal peptide-derived antigen and its specific T-cell receptor for T-cell immunotherapy.
Li Z; Gong H; Liu Q; Wu W; Cheng J; Mei Y; Chen Y; Zheng H; Yu X; Zhong S; Li Y
Immunology; 2020 Apr; 159(4):384-392. PubMed ID: 31849039
[TBL] [Abstract][Full Text] [Related]
14. Lack of ex vivo peripheral and intrahepatic α-fetoprotein-specific CD4+ responses in hepatocellular carcinoma.
Witkowski M; Spangenberg HC; Neumann-Haefelin C; Büttner N; Breous E; Kersting N; Drognitz O; Hopt UT; Blum HE; Semmo N; Thimme R
Int J Cancer; 2011 Nov; 129(9):2171-82. PubMed ID: 21170957
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor effects of immunotherapeutic peptide on the treatment of hepatocellular carcinoma with HBc carrier.
Kong J; Diao Z; Deng X; Zhong H; Yao W; Hu X
Oncol Rep; 2007 Jul; 18(1):279-85. PubMed ID: 17549380
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in immunotherapy for hepatocellular cancer.
Butterfield LH
Swiss Med Wkly; 2007 Feb; 137(5-6):83-90. PubMed ID: 17370144
[TBL] [Abstract][Full Text] [Related]
17. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of hepatocellular carcinoma with a vaccine based on xenogeneic homologous alpha fetoprotein in mice.
Zhang W; Liu J; Wu Y; Xiao F; Wang Y; Wang R; Yang H; Wang G; Yang J; Deng H; Li J; Wen Y; Wei Y
Biochem Biophys Res Commun; 2008 Nov; 376(1):10-4. PubMed ID: 18725206
[TBL] [Abstract][Full Text] [Related]
19. Glycoprotein 96 and α-fetoprotein cross-linking complexes elicited specific antitumor immunity.
Wang XP; Wang QX; Lin HP; Wang YL; Yang Y
Cancer Biother Radiopharm; 2013 Jun; 28(5):406-14. PubMed ID: 23484810
[TBL] [Abstract][Full Text] [Related]
20. Application of cancer-testis antigens in immunotherapy of hepatocellular carcinoma.
Seifi-Alan M; Shamsi R; Ghafouri-Fard S
Immunotherapy; 2018 Apr; 10(5):411-421. PubMed ID: 29473472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
